Puma Biotechnology (PBYI) Work In Process (2020 - 2026)
Puma Biotechnology (PBYI) reported Work In Process of $1.79 million for Q2 2026, up 35.0% from $1.33 million a year earlier but down 7.0% from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Work In Process (2020 - 2026) Analysis & Trends
At the end of FY2025, Puma Biotechnology posted Work In Process of $1.34 million, up 77.2% from FY2024.
- Work In Process has a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- By year, Work In Process came in at $758,000 in FY2024 (-7.6%), $820,000 in FY2023 (-69.2%), $2.66 million in FY2022 (+92.1%) and $1.39 million in FY2021 (+10.1%).
- Five-year quarterly Work In Process spans a low of $758,000 in Q4 2024 and a high of $7.77 million in Q2 2024.
- Year over year, Work In Process has now increased in each of the last four quarters, with growth averaging 22.5% over the last eight quarters.
- The high point for year-over-year Work In Process in five years was Q3 2025 (growth of 169.1%); the low point was Q2 2025 (a decline of 82.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.93 million (Q1 2026), $1.34 million (Q4 2025) and $5.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Puma Biotechnology | 556.52 Mn | 169.15 Mn | 44.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Mn |
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 5.40 Mn |
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 758,000.00 |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 820,000.00 |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 2.66 Mn |
| Sep 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 3.12 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Dec 31, 2020 | 1.26 Mn |
API Access
Puma Biotechnology Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();